DE60124907D1 - VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01) - Google Patents

VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01)

Info

Publication number
DE60124907D1
DE60124907D1 DE60124907T DE60124907T DE60124907D1 DE 60124907 D1 DE60124907 D1 DE 60124907D1 DE 60124907 T DE60124907 T DE 60124907T DE 60124907 T DE60124907 T DE 60124907T DE 60124907 D1 DE60124907 D1 DE 60124907D1
Authority
DE
Germany
Prior art keywords
acid
derivative
dioxan
hydroxymethyl
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60124907T
Other languages
English (en)
Inventor
Akira Nishiyama
Miho Horikawa
Yoshihiko Yasohara
Noboru Ueyama
Kenji Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of DE60124907D1 publication Critical patent/DE60124907D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60124907T 2000-06-05 2001-06-05 VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01) Expired - Lifetime DE60124907D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000168285 2000-06-05
PCT/JP2001/004729 WO2001094337A1 (fr) 2000-06-05 2001-06-05 Procede de preparation de derives optiquement actifs d'acide 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetique

Publications (1)

Publication Number Publication Date
DE60124907D1 true DE60124907D1 (de) 2007-01-11

Family

ID=18671311

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124907T Expired - Lifetime DE60124907D1 (de) 2000-06-05 2001-06-05 VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01)

Country Status (9)

Country Link
US (2) US7094594B2 (de)
EP (1) EP1288213B1 (de)
KR (1) KR20020068496A (de)
AT (1) ATE346848T1 (de)
AU (1) AU6269201A (de)
CA (1) CA2380997A1 (de)
DE (1) DE60124907D1 (de)
SI (1) SI20874A (de)
WO (1) WO2001094337A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
EP1478625A1 (de) 2002-02-27 2004-11-24 Pfizer Products Inc. Zur herstellung von agonisten des beta-3-adrenergen rezeptors geeignete verfahren und zwischenprodukte
EP1568679A4 (de) * 2002-12-06 2012-08-29 Kaneka Corp HERSTELLUNGSVERFAHREN F R OPTISCH AKTIVE 3-MILCHSûUREESTER-DERIVATE
DE10352659B4 (de) * 2003-11-11 2007-09-13 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren
US20100003732A1 (en) * 2005-05-31 2010-01-07 Kaneka Corporation Process for production of optically active 2-substituted propanal derivative
ZA200711038B (en) 2005-06-02 2009-06-24 Cargill Inc Genetically modified yeast of the species Issatchenkia orientalis and closely related species and fermentation processes using same
JP2009142256A (ja) * 2007-03-19 2009-07-02 Sumitomo Chemical Co Ltd Ｄ−乳酸の製造方法
EP2247739B1 (de) * 2008-01-23 2018-05-16 LEK Pharmaceuticals d.d. ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate und verfahren zu seiner herstellung unter verwendung einer 2-desoxyribose-5-phosphat aldolase (dera)
KR101130717B1 (ko) * 2008-05-14 2012-03-28 웰이앤씨 주식회사 ＨＭＧ-ＣｏＡ 환원 저해제의 제조를 위한 키랄 중간체의제조방법
CN102876734B (zh) * 2012-10-30 2014-01-01 华东理工大学 一种羰基还原酶、基因及其在不对称还原前手性羰基化合物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE894067L (en) 1988-12-21 1990-06-21 Ackley Michael Process for the production of 3,5,6-trihydroxyhexanoic acid¹derivative
JP2619136B2 (ja) 1990-11-02 1997-06-11 鐘淵化学工業株式会社 ５，６―ジヒドロキシ―３―オキソヘキサン酸エステル誘導体の製造法
JP3149265B2 (ja) 1992-05-12 2001-03-26 鐘淵化学工業株式会社 光学活性な３，５−ジヒドロキシ脂肪酸エステル誘導体の製造法
DE59307409D1 (de) 1992-07-02 1997-10-30 Hoechst Ag Verfahren zur Herstellung von (3R,5S)6-Hydroxy-3,5-0-isopropyliden-3,5-dihydroxy-hexansäure-tert.-butylester
DE69942897D1 (de) * 1998-08-05 2010-12-09 Kaneka Corp Verfahren zur Herstellung optisch aktiver 2-Ä6-(Hydroxymethyl)-1,3-Dioxan-4-ylÜ-Essigsäure-Derivate
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process

Also Published As

Publication number Publication date
US20050080277A1 (en) 2005-04-14
KR20020068496A (ko) 2002-08-27
SI20874A (sl) 2002-10-31
EP1288213A1 (de) 2003-03-05
EP1288213A4 (de) 2004-03-31
CA2380997A1 (en) 2001-12-13
AU6269201A (en) 2001-12-17
US20060246557A1 (en) 2006-11-02
ATE346848T1 (de) 2006-12-15
US7094594B2 (en) 2006-08-22
WO2001094337A1 (fr) 2001-12-13
EP1288213B1 (de) 2006-11-29

Similar Documents

Publication Publication Date Title
ATE375989T1 (de) Verfahren zur herstellung von 3,5-dihydroxy substituierten estern als zwischenprodukte zur herstellung optisch aktiver 2-(6-(hydroxymethyl)- 1,3-dioxan-4-yl)-essigsäure-derivate
DE60124907D1 (de) VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01)
ATE348814T1 (de) Verfahren zur herstellung von chinolinderivaten
ATE543793T1 (de) Verfahren zur herstellung von benzoesäureestern
ATE125544T1 (de) Verfahren zur herstellung von amikacin.
ATE276998T1 (de) Verfahren zur herstellung von (nitroxymethyl)phenylestern von salicylsäurederivaten
DE60009836D1 (de) Verfahren zur herstellung von 5-hydroxy-3-oxo-pentansäure-derivaten
ATE420073T1 (de) Verfahren und zwischenprodukte zur herstellung 2- substituierter piperidinstereoisomere
DE69523038D1 (de) Verfahren zur herstellung von hiv proteasinhibitoren
ATE355263T1 (de) Verfahren zur herstellung von(4e)-5-chloro-2- isopropyl-4-pentensäureester und optischaktivem isomer davon
ATE384067T1 (de) Verfahren zur herstellung von 3-cephemderivaten
DE50009219D1 (de) Verfahren zur herstellung von estern
ATE222585T1 (de) Verfahren zur herstellung von 4-hydroxy-2- pyrrolidon
DE60010918D1 (de) Verfahren zur herstellung von 7-azabicyclo (4.1.0)-hept-3-ene-3-carbonsäureestern
KR860001085A (ko) 티아졸릴프로펜디카르복실산 반 에스테르류의 제조방법
ATE313531T1 (de) Verfahren zur herstellung von hexahydropyridazin- 3-carbonsäure-derivaten
DE3861034D1 (de) Verfahren zur herstellung von azetidinon-1-oxoessigsaeureester durch oxydation des uebereinstimmenden 2-hydroxyessigsaeureesters.
DE3765810D1 (de) Verfahren zur herstellung von 1h-pyrrolizin-3,5-(2h,6h)-dionen.
ATE130612T1 (de) Verfahren für die herstellung von bizyklischen beta-laktamen.
ATE213493T1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
ATE179417T1 (de) Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung
ATE240937T1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
ATE193517T1 (de) Verfahren zur herstellung von optisch aktiven carbonsäuren
ATE222226T1 (de) Verfahren zur herstellung von 1- bromalkylbenzolderivaten und zwischenprodukte davon
ATE58721T1 (de) Reine kristallisierte wasserfreie acrylamidoglycolsaeure und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8332 No legal effect for de